Dna X (SONM) Payables (2018 - 2026)

Dna X has reported Payables for 9 years, with the latest figure at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 90.84% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 90.84% YoY), and the FY2025 full-year result was $5.1 million, up 586.31% from the prior year.
• Payables for Q1 2026 stood at $1.8 million, down from $5.1 million in the prior quarter.
• The five-year high for Payables was $23.5 million in Q2 2025, with the low at $738000.0 in Q4 2024.
• Historically, Payables has averaged $14.0 million across 5 years, with a median of $13.4 million in 2022.
• Annual changes were most pronounced in 2024 — Payables plunged 96.28% — and 2025, when it soared 586.31%.
• Dna X's Payables stood at $21.1 million in 2022, then slipped by 6.05% to $19.8 million in 2023, then sank by 96.28% to $738000.0 in 2024, then soared by 586.31% to $5.1 million in 2025, then slumped by 64.64% to $1.8 million in 2026.
• The last three Payables figures came in at $1.8 million (Q1 2026), $5.1 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.